US Patent 11618751 Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives

Patent 11618751 was granted and assigned to Ventus Therapeutics U.S., Inc. on April, 2023 by the United States Patent and Trademark Office.